Havas Health & You announced their continued investment in Customer Experience and Innovation with several leadership changes.
Jean-Noel David, Managing Director at Seqens CDMO NA, identifies six key trends that promise to reshape the pharma landscape during 2021 and beyond.
Much of the conversation at CES 2021 had to do with the emergence of “digital leaders” and “digital laggards” and what an organization finding itself behind the digital transformation curve can do to pull forward.
This white paper from Abbott examines a cross-section of the global healthcare system leveraging primary research with 1,400+ respondents including patients, physicians, and administrators.
AstraZeneca entered into a definitive agreement to acquire Alexion Pharmaceuticals for a total consideration to Alexion shareholders of $39 billion or $175 per share.
RA Capital Management closed the venture capital firm’s second venture fund at $461 million, aimed at a continued investment strategy into privately held life sciences companies.
Fernando Fernandez, Managing Director of FCB Health Network’s BX – Brand Experience Design Group, talked to Med Ad News about how COVID-19 has changed the way people interact with brands, how branding innovations such as audio and motion identities are making their way to pharma, and other topics.
EVERSANA launched ACTICS by EVERSANA, a technology-enabled solution to optimize end-to-end commercial success for life science companies.
Fingerpaint, a full-service health and wellness agency with five offices across the United States and nearly $80 million in revenue, announced that Nick Bartolomeo and Bryan O’Malley have been promoted to head of media and performance marketing and head of technology and performance innovation, respectively.
Blue Knight, a program created in partnership with Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA), chose seven startups from J&J’s global JLABS incubator network to participate in the fight against the world’s current Covid-19 pandemic and future ones.